Gsk annual free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Gsk Free Cash Flow (FCF) History (GSK)
Gsk reported £6.39B in free cash flow for fiscal 2025, an increase of 24.02% from the previous fiscal year, with a free cash flow margin of 19.57%.
View full Gsk company overviewGsk free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | £6.39B | £1.24B | +24.02% | +19.57% |
| 2024 | 2024-12-31 | £5.16B | −£299.0M | −5.48% | +16.43% |
| 2023 | 2023-12-31 | £5.45B | −£806.0M | −12.88% | +17.98% |
| 2022 | 2022-12-31 | £6.26B | −£742.0M | −10.60% | +21.35% |
| 2021 | 2021-12-31 | £7.00B | −£450.0M | −6.04% | +28.35% |
| 2020 | 2020-12-31 | £7.45B | £697.0M | +10.32% | +30.60% |
| 2019 | 2019-12-31 | £6.75B | −£322.0M | −4.55% | +20.01% |
| 2018 | 2018-12-31 | £7.08B | £1.70B | +31.71% | +22.96% |
| 2017 | 2017-12-31 | £5.37B | £419.0M | +8.46% | +17.80% |
| 2016 | 2016-12-31 | £4.95B | £3.77B | +316.65% | +17.76% |
| 2015 | 2015-12-31 | £1.19B | — | — | +4.97% |
Gsk quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Gsk free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from £7.45B to £6.39B, a compound annual decline of 3.02%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Gsk filings at SEC.gov ↗